Lei Lyu

403 total citations
19 papers, 292 citations indexed

About

Lei Lyu is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lei Lyu has authored 19 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lei Lyu's work include Liver physiology and pathology (4 papers), Ferroptosis and cancer prognosis (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Lei Lyu is often cited by papers focused on Liver physiology and pathology (4 papers), Ferroptosis and cancer prognosis (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Lei Lyu collaborates with scholars based in China, United States and Australia. Lei Lyu's co-authors include Wei Xiang, Tao Huang, Yinong Duan, Dandan Zhu, Jinling Chen, Min‐Lee Chang, Allen Taylor, Shuhong Jiang, Fuxin Zheng and Fu Shang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomaterials and Scientific Reports.

In The Last Decade

Lei Lyu

16 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lei Lyu China	10	177	64	51	37	30	19	292
Jianwen Chen China	11	174 1.0×	94 1.5×	33 0.6×	15 0.4×	69 2.3×	21	360
Mojtaba Darbouy Iran	11	203 1.1×	62 1.0×	79 1.5×	35 0.9×	14 0.5×	25	363
Liang Da China	9	150 0.8×	53 0.8×	215 4.2×	31 0.8×	26 0.9×	13	347
Lakshmi Gopinathan United States	9	198 1.1×	52 0.8×	51 1.0×	7 0.2×	13 0.4×	11	331
Nadire R. Cochran Switzerland	4	192 1.1×	35 0.5×	180 3.5×	19 0.5×	35 1.2×	5	298
Alexia Hervieu United Kingdom	5	106 0.6×	23 0.4×	36 0.7×	22 0.6×	23 0.8×	8	185
Jiang Chen China	10	179 1.0×	34 0.5×	79 1.5×	63 1.7×	26 0.9×	12	303
Malinee Thanee Thailand	12	155 0.9×	109 1.7×	24 0.5×	7 0.2×	26 0.9×	37	372
Yongjia Tong China	9	193 1.1×	83 1.3×	24 0.5×	6 0.2×	36 1.2×	15	329

Countries citing papers authored by Lei Lyu

Since Specialization

Citations

This map shows the geographic impact of Lei Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Lyu more than expected).

Fields of papers citing papers by Lei Lyu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Lyu. The network helps show where Lei Lyu may publish in the future.

Co-authorship network of co-authors of Lei Lyu

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Lyu. A scholar is included among the top collaborators of Lei Lyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Lyu. Lei Lyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Chen, Feilong, Lei Lyu, Chengyuan Xing, et al.. (2025). The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment. Frontiers in Oncology. 15. 1649179–1649179.

Hu, Yongwei, Wang Li, Lei Lyu, et al.. (2025). Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma. Biomaterials. 329. 123899–123899.

Wang, Yuli, Qihong Ni, Yongjie Yao, et al.. (2025). Vitamin D supplementation inhibits atherosclerosis through repressing macrophage-induced inflammation via SIRT1/mTORC2 signaling. Chinese Medical Journal. 138(21). 2841–2843.

Chen, Feilong, Zhiyu Li, Yu Fu, et al.. (2025). MOTS-c mimics exercise to combat diabetic liver fibrosis by targeting Keap1-Nrf2-Smad2/3. Scientific Reports. 15(1). 18460–18460. 2 indexed citations

Zhu, Dunru, et al.. (2025). Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma. Journal of Nanobiotechnology. 23(1). 317–317. 2 indexed citations

Lyu, Lei, Rui Min, Fuxin Zheng, et al.. (2024). Prognostic value of inflammation and immune-related gene NOD2 in clear cell renal cell carcinoma. Human Cell. 37(3). 782–800. 1 indexed citations

Lyu, Lei, et al.. (2020). Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma. Frontiers in Oncology. 10. 1613–1613. 14 indexed citations

Xiang, Wei, et al.. (2020). The long non‐coding RNA SNHG1 promotes bladder cancer progression by interacting with miR‐143‐3p and EZH2. Journal of Cellular and Molecular Medicine. 24(20). 11858–11873. 27 indexed citations

Lyu, Lei, et al.. (2019). Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway. Pulmonary Pharmacology & Therapeutics. 56. 69–74. 31 indexed citations

10.

Lyu, Lei, et al.. (2019). <p>Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer</p>. Cancer Management and Research. Volume 11. 6061–6077. 27 indexed citations

11.

Lyu, Lei, et al.. (2018). Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis. Drug Design Development and Therapy. Volume 12. 743–756. 27 indexed citations

12.

Zhu, Dandan, Lei Lyu, Pei Shen, et al.. (2018). rSjP40 protein promotes PPARγ expression in LX‐2 cells through microRNA‐27b. The FASEB Journal. 32(9). 4798–4803. 16 indexed citations

13.

Walker, Alison, Ying Li, Lei Lyu, et al.. (2017). Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines. Leukemia Research. 60. 129–134. 3 indexed citations

14.

Duan, Yinong, Lei Lyu, Dandan Zhu, et al.. (2017). Recombinant SjP40 protein enhances p27 promoter expression in hepatic stellate cells via an E2F1-dependent mechanism. Oncotarget. 8(25). 40705–40712. 6 indexed citations

15.

Wang, Jianxin, Wenxia Peng, Jinrong Feng, et al.. (2016). Recombinant T2 RNase protein of Schistosoma japonicum inhibits expression of α-SMA in LX-2 cells. Parasitology Research. 115(10). 4055–4060. 2 indexed citations

16.

Chen, Jinling, Tianhua Xu, Dandan Zhu, et al.. (2016). Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway. Cell Death and Disease. 7(7). e2315–e2315. 40 indexed citations

17.

Liu, Ke, Lei Lyu, David A. Chin, et al.. (2015). Altered ubiquitin causes perturbed calcium homeostasis, hyperactivation of calpain, dysregulated differentiation, and cataract. Proceedings of the National Academy of Sciences. 112(4). 1071–1076. 52 indexed citations

18.

Zhou, Lyu, Lei Lyu, Jun Liu, et al.. (2015). Sch9 regulates intracellular protein ubiquitination by controlling stress responses. Redox Biology. 5. 290–300. 12 indexed citations

19.

Lyu, Lei, Elizabeth A. Whitcomb, Shuhong Jiang, et al.. (2015). Unfolded‐protein response‐associated stabilization of p27(Cdkn1b) interferes with lens fiber cell denucleation, leading to cataract. The FASEB Journal. 30(3). 1087–1095. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact